NCT07759284

Brief Summary

This is a case-control study designed to enroll 224 patients who will undergo tracheal intubation for general anesthesia in the operating rooms of Peking University People's Hospital between July 20, 2026, and October 31, 2026. The case group will consist of patients who develop coughing before extubation (N=112), while the control group will comprise those without coughing before extubation (N=112). Data to be collected include general demographic characteristics, smoking and smoking cessation history, comorbid conditions (with particular attention to snoring during sleep and sleep apnea-hypopnea syndrome \[SAHS\]), history of pulmonary diseases, mode of spontaneous breathing, surgical and anesthetic data, as well as blood pressure and heart rate before, during, and after extubation, pain scores, and sedation levels. Continuous variables will be presented as mean ± standard deviation (for normally distributed data) or median with interquartile range (IQR) (for non-normally distributed data). Categorical variables will be described using frequencies and percentages (e.g., sex, smoking history). Baseline differences between the case and control groups will be compared using the chi-square test (for categorical variables), Student's t-test (for normally distributed continuous variables), or the Mann-Whitney U test (for non-normally distributed continuous variables). Multivariable logistic regression analysis will be employed to evaluate the independent association between the mode of spontaneous breathing and coughing before extubation, with adjustment for potential confounding factors, and odds ratios (ORs) with their 95% confidence intervals (95%CI) will be calculated. All statistical analyses will be performed using SPSS or R software.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
224

participants targeted

Target at P75+ for all trials

Timeline
2mo left

Started Sep 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 22, 2026

Completed
21 days until next milestone

First Posted

Study publicly available on registry

August 12, 2026

Completed
20 days until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2026

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2026

Last Updated

August 12, 2026

Status Verified

July 1, 2026

Enrollment Period

2 months

First QC Date

July 22, 2026

Last Update Submit

August 11, 2026

Conditions

Keywords

Oronasal Breathing PatternEndotracheal Tube IntoleranceEmergence from General AnaesthesiaNested Case-Control Study

Outcome Measures

Primary Outcomes (1)

  • Endotracheal Tube Intolerance

    Definition of Bucking / Emergence Coughing: Bucking is defined as a reflexive cough occurring during the emergence phase following the administration of reversal agents at the conclusion of surgery. It manifests while the patient is mechanically ventilated in the manual ventilation mode via the endotracheal tube (with the adjustable pressure-limiting \[APL\] valve set at 0 cmH₂O), after extubation criteria have been met but prior to the actual removal of the tracheal tube. Severity Grading of Bucking (Clinical Scale): Grade 0: No bucking. Grade 1: Isolated, single cough. Grade 2: Intermittent coughing (more than one episode, non-sustained). Grade 3: Sustained, repetitive coughing accompanied by head lifting (indicating severe emergence agitation/reflex).

    Pre-extubation period

Study Arms (2)

Mouth Breathing

The patients' breathing pattern is predominantly oral.

Nasal Breathing

The patients' breathing pattern is predominantly nasal.

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

A total of 224 patients undergoing general anesthesia with endotracheal intubation in the operating rooms of Peking University People's Hospital will be recruited between July 20, 2026, and October 31, 2026.

You may qualify if:

  • Patients undergoing general anesthesia with endotracheal intubation;
  • Written informed consent obtained.

You may not qualify if:

  • Patients with severe psychiatric disorders;
  • Deaf or mute patients who are unable to answer questions;
  • Patients who develop postoperative cognitive dysfunction and are consequently unable to answer questions;
  • Patients who withdraw from the study prematurely;
  • Patients who are extubated after being transferred to the recovery room or intensive care unit (i.e., extubation not performed in the operating room).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (21)

  • Cui XL, Ma MJ, Wang L, Yu XR, Huang YG. Influence of Sex on Remifentanil's Cough-prevention Effect during Anesthetic Emergence. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2015 Jun;37(3):335-8. doi: 10.3881/j.issn.1000-503X.2015.03.017.

  • Salim B, Rashid S, Ali MA, Raza A, Khan FA. Effect of Pharmacological Agents Administered for Attenuating the Extubation Response on the Quality of Extubation: A Systematic Review. Cureus. 2019 Dec 20;11(12):e6427. doi: 10.7759/cureus.6427.

  • Chang CH, Lee JW, Choi JR, Shim YH. Effect-site concentration of remifentanil to prevent cough after laryngomicrosurgery. Laryngoscope. 2013 Dec;123(12):3105-9. doi: 10.1002/lary.24199. Epub 2013 May 31.

  • Lee SY, Yoo JY, Kim JY, Kim DH, Lee JD, Rho GU, Park H, Park SY. Optimal effect-site concentration of remifentanil for preventing cough during removal of the double-lumen endotracheal tube from sevoflurane-remifentanil anesthesia: A prospective clinical trial. Medicine (Baltimore). 2016 Jun;95(24):e3878. doi: 10.1097/MD.0000000000003878.

  • Fan X, Cai H, Pan B, Xie Y. Comparison of dexmedetomidine and remifentanil on reducing coughing during emergence from anesthesia with tracheal intubation: A meta-analysis. Front Pharmacol. 2022 Sep 30;13:993239. doi: 10.3389/fphar.2022.993239. eCollection 2022.

  • Sakae TM, Souza RLP, Brand Uo JCM. Impact of topical airway anesthesia on immediate postoperative cough/bucking: a systematic review and meta-analysis. Braz J Anesthesiol. 2023 Jan-Feb;73(1):91-100. doi: 10.1016/j.bjane.2021.03.016. Epub 2021 Apr 22.

  • Lv L, Yan L, Liu X, Chen M. Effectiveness of lidocaine/prilocaine cream on cardiovascular reactions from endotracheal intubation and cough events during recovery period of older patients under general anesthesia: prospective, randomized placebo-controlled study. BMC Geriatr. 2020 May 4;20(1):157. doi: 10.1186/s12877-020-01567-y.

  • Viguera M, Diakum TA, Shelsky R, Casals P, Cochs J, Fauli A. [Efficacy of topical administration of lidocaine through a Malinckrodt Hi-Lo Jet tube in lessening cough during recovery from general anesthesia]. Rev Esp Anestesiol Reanim. 1992 Sep-Oct;39(5):316-8. Spanish.

  • Hartley M, Vaughan RS. Problems associated with tracheal extubation. Br J Anaesth. 1993 Oct;71(4):561-8. doi: 10.1093/bja/71.4.561. No abstract available.

  • Lee JS, Choi SH, Kang YR, Kim Y, Shim YH. Efficacy of a single dose of dexmedetomidine for cough suppression during anesthetic emergence: a randomized controlled trial. Can J Anaesth. 2015 Apr;62(4):392-8. doi: 10.1007/s12630-014-0295-6. Epub 2014 Dec 19.

  • Miller KA, Harkin CP, Bailey PL. Postoperative tracheal extubation. Anesth Analg. 1995 Jan;80(1):149-72. doi: 10.1097/00000539-199501000-00025. No abstract available.

  • Dyson A, Isaac PA, Pennant JH, Giesecke AH, Lipton JM. Esmolol attenuates cardiovascular responses to extubation. Anesth Analg. 1990 Dec;71(6):675-8. doi: 10.1213/00000539-199012000-00017.

  • Fang P, Zong Z, Lu Y, Han X, Liu X. Effect of topical ropivacaine on the response to endotracheal tube during emergence from general anesthesia: a prospective randomized double-blind controlled study. BMC Anesthesiol. 2018 Sep 27;18(1):134. doi: 10.1186/s12871-018-0601-x.

  • Takahata O, Iwasaki H. [Problems and complications in airway management by endotracheal intubation and laryngeal mask airway]. Masui. 2006 Jan;55(1):44-50. Japanese.

  • Frerk C, Mitchell VS, McNarry AF, Mendonca C, Bhagrath R, Patel A, O'Sullivan EP, Woodall NM, Ahmad I; Difficult Airway Society intubation guidelines working group. Difficult Airway Society 2015 guidelines for management of unanticipated difficult intubation in adults. Br J Anaesth. 2015 Dec;115(6):827-48. doi: 10.1093/bja/aev371. Epub 2015 Nov 10.

  • Ni Eochagain A, Athanassoglou V, Cumberworth A, Morris O, Corbett S, Jefferson H, O'Sullivan EP, Pandit JJ. Assessing a novel second generation laryngeal mask airway using the 'ADEPT' approach: results from the LMA(R) Protector observational study. J Clin Monit Comput. 2023 Apr;37(2):517-524. doi: 10.1007/s10877-022-00910-5. Epub 2022 Sep 5.

  • Kleine-Brueggeney M, Gottfried A, Nabecker S, Greif R, Book M, Theiler L. Pediatric supraglottic airway devices in clinical practice: A prospective observational study. BMC Anesthesiol. 2017 Sep 2;17(1):119. doi: 10.1186/s12871-017-0403-6.

  • Sharma B, Sahai C, Sood J. Extraglottic airway devices: technology update. Med Devices (Auckl). 2017 Aug 17;10:189-205. doi: 10.2147/MDER.S110186. eCollection 2017.

  • Brain AI. The laryngeal mask--a new concept in airway management. Br J Anaesth. 1983 Aug;55(8):801-5. doi: 10.1093/bja/55.8.801.

  • Durbin CG Jr, Bell CT, Shilling AM. Elective intubation. Respir Care. 2014 Jun;59(6):825-46; discussion 847-9. doi: 10.4187/respcare.02802.

  • Weiser TG, Haynes AB, Molina G, Lipsitz SR, Esquivel MM, Uribe-Leitz T, Fu R, Azad T, Chao TE, Berry WR, Gawande AA. Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes. Lancet. 2015 Apr 27;385 Suppl 2:S11. doi: 10.1016/S0140-6736(15)60806-6. Epub 2015 Apr 26.

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief of Anesthesiology

Study Record Dates

First Submitted

July 22, 2026

First Posted

August 12, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

October 31, 2026

Study Completion (Estimated)

October 31, 2026

Last Updated

August 12, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

The confidentiality of all patient information will be strictly maintained.